作者
Souichi Yanamoto, Tsutomu Iwamoto, Goro Kawasaki, Izumi Yoshitomi, Nobuyuki Baba, Akio Mizuno
发表日期
2005/6/1
期刊
Cancer letters
卷号
223
期号
1
页码范围
67-76
出版商
Elsevier
简介
The p53R2 gene encodes the ribonucleotide reductase (RR) small subunit 2 homologue, and is induced by several stress signals activating p53, such as DNA-damaging agents. The p53R2 gene product causes an increase in the deoxynucleotide triphosphate (dNTP) pool in the nucleus, which facilitates DNA repair and synthesis. We hypothesized that p53R2 would be a good molecular target for cancer gene therapy. In this study, three human oral cancer cell lines (SAS, HSC-4 and Ca9-22), a human breast cancer cell line MCF-7, and a normal human fibroblast cell line NHDF were tested. We silenced the expression of p53R2 with the highly specific post-transcriptional suppression of RNA interference (RNAi). We investigated p53R2 expression with the reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting. The sensitivity to anticancer agents was evaluated by a 3-(4,5-dimethylthiazol-2 …
引用总数
学术搜索中的文章
S Yanamoto, T Iwamoto, G Kawasaki, I Yoshitomi… - Cancer letters, 2005